Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120076754 Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
03/29/2012US20120076750 Fibrin based glue with functionalized hydrophilic polymer protein binding agent
03/29/2012US20120076744 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076740 Water soluble pharmaceutical compositions of hops resins
03/29/2012US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
03/29/2012US20120076738 Combination treatment for dermatological conditions
03/29/2012US20120076735 Nanoparticles for Extravascular Administration
03/29/2012US20120076734 Radiopaque antibiotic dental paste and uses thereof
03/29/2012US20120076732 Phosphodiesterase inhibitors and uses thereof
03/29/2012US20120076731 Lymphedema associated genes and model
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012US20120076729 Methods of treating cancers
03/29/2012US20120076723 Devices and methods for the treatment of cancer
03/29/2012US20120074026 Pharmaceutical foam
03/29/2012US20120074014 Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication
03/29/2012US20120073508 Insulin-like gene in prawns and uses thereof
03/29/2012DE202007019385U1 Pharmazeutische Zusammensetzungen, umfassend Clopidogrel Pharmaceutical compositions comprising clopidogrel
03/29/2012DE10217356B4 Lösung für die Peritonealdialyse Solution for peritoneal dialysis
03/29/2012DE102010046866A1 Diagnosing diseases of central nervous system e.g. primary lymphoma, comprises determining content of microRNA highly diagnostic for presence or absence of disease in a sample of cerebrospinal fluid, and comparing with a reference value
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012DE102010046720A1 Verfahren zur Herstellung von pan-CDK-Inhibitoren der Formel (l), sowie Intermediate der Herstellung A process for producing pan-CDK inhibitors of the formula (l), as well as intermediates of the preparation of
03/29/2012DE102010046512A1 Phosphorhaltige Metallkomplexe Phosphorus-containing metal complexes
03/29/2012DE102010046412A1 Metall-Ligand Koordinationsverbindungen Metal-ligand coordination compounds
03/29/2012CA2846460A1 Aprepitant l-proline composition and cocrystal
03/29/2012CA2830703A1 Viral inhibitor composition for in vivo therapeutic use
03/29/2012CA2812999A1 Composition comprising sod, lutein and zeaxanthin
03/29/2012CA2812962A1 Azido nucleosides and nucleotide analogs
03/29/2012CA2812699A1 Hepatitis c virus inhibitors
03/29/2012CA2812570A1 Controlled release formulations of opioids
03/29/2012CA2812467A1 Atropisomers of pi3k-inhibiting compounds
03/29/2012CA2812449A1 Oxadiazole inhibitors of leukotriene production
03/29/2012CA2812378A1 Fused tricyclic compounds as adenosine receptor antagonist
03/29/2012CA2812372A1 Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
03/29/2012CA2812363A1 Substituted polycyclic carbamoyl pyridone derivative prodrug
03/29/2012CA2812362A1 Matrix metalloproteinase inhibitors
03/29/2012CA2812361A1 Matrix metalloproteinase inhibitors
03/29/2012CA2812319A1 Matrix metalloproteinase inhibitors
03/29/2012CA2812299A1 Administration of serine protease inhibitors to the stomach
03/29/2012CA2812263A1 Corticosteroid particles and method of production
03/29/2012CA2812262A1 Aerosol composition for administering drugs
03/29/2012CA2812109A1 Methods and compositions for treatment of diabetes and dyslipidemia
03/29/2012CA2812061A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
03/29/2012CA2811912A1 Novel polymorphs of febuxostat
03/29/2012CA2811895A1 Cyclopropane compounds
03/29/2012CA2811714A1 Imidazotriazinone compounds
03/29/2012CA2811692A1 Novel block copolymer and micelle compositions and methods of use thereof
03/29/2012CA2811634A1 Antidiabetic solid pharmaceutical compositions
03/29/2012CA2811567A1 Deubiquitinase inhibitors and methods for use of the same
03/29/2012CA2810928A1 Substituted nucleotide analogs
03/29/2012CA2810706A1 Substituted amide compound
03/29/2012CA2810356A1 Buprenorphine analogs
03/29/2012CA2810112A1 Caspofungin composition
03/29/2012CA2809858A1 Novel low molecular weight cationic lipids for oligonucleotide delivery
03/29/2012CA2809762A1 Methods and compositions for treating lung cancer
03/29/2012CA2809675A1 Monohydrate of an azaadamantane derivative
03/29/2012CA2809646A1 5.alpha.-androstane-3.beta.,5,6.beta.-triol injection and preparation method therefor
03/29/2012CA2809557A1 Pyrazolopyridines as inhibitors of the kinase lrrk2
03/29/2012CA2809509A1 Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease
03/29/2012CA2809489A1 Materials and methods for improving gastrointestinal function
03/29/2012CA2809217A1 Pyrimidones for treatment of potassium channel related diseases
03/29/2012CA2808662A1 Xenon-based anesthetic gas composition usable during an endarterectomy involving the clamping of the carotid artery
03/29/2012CA2807904A1 4,7-dihydro-pyrazolo[1,5-a]pyrazin-6-ylamine derivatives useful as inhibitors of beta-secretase (bace)
03/29/2012CA2807496A1 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
03/29/2012CA2806121A1 Pharmaceutical composition
03/29/2012CA2780785A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
03/29/2012CA2780771A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing sames
03/28/2012EP2434290A1 Blood coagulation time prolonging agent
03/28/2012EP2434282A2 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers
03/28/2012EP2434010A1 Prophylactic and/or therapeutic agent for metabolic syndrome
03/28/2012EP2433948A1 Use of a new class of nucleotide sugar as antibiotic or cytostatic agent
03/28/2012EP2433943A1 Thienopyrazole derivatives having PDE7 inhibitory activity
03/28/2012EP2433940A1 Spiroimidazolone derivative
03/28/2012EP2433939A1 Substituted 8-sulfonyl-2,3,4,5-tetrahydro-1h-gamma-carbolines, ligands and pharmaceutical composition; method for the production and use of same
03/28/2012EP2433938A1 Therapeutic agent for motor disorders
03/28/2012EP2433937A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433936A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433935A1 Substituted-quinoxaline-type-piperidine compounds and the uses thereof
03/28/2012EP2433932A1 Prophylactic And/Or Therapeutic Agent For Hyperlipidemia
03/28/2012EP2433926A1 Pleuromutilin derivatives for use in the treatment of diseases mediated by microbes
03/28/2012EP2433653A1 Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
03/28/2012EP2433637A1 Use of quinazoline derivatives for neurodegenerative diseases
03/28/2012EP2433636A1 Treatment of Malignant Diseases
03/28/2012EP2433635A1 PAK Modulators
03/28/2012EP2433634A2 Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/28/2012EP2433633A1 Triazolyl alpha -mercaptoacetanildes as inhibitors of HIV reverse transcriptase
03/28/2012EP2433632A1 Compositions and combinations comprising non-racemic 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol, for use in medicine
03/28/2012EP2433631A2 Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients
03/28/2012EP2433630A1 Self-emulsifying composition of 3 fatty acid
03/28/2012EP2433629A1 Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of Langerhans
03/28/2012EP2433628A1 Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
03/28/2012EP2433627A1 Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
03/28/2012EP2433626A1 Compositions and Methods for Treatment of Cardiovascular Disorders and Diseases
03/28/2012EP2433625A1 Anti-obesity agent comprising compound containing benzotropolone ring
03/28/2012EP2433624A1 Use of buparvaquone for controlling mites parasitising honeybees
03/28/2012EP2433623A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism
03/28/2012EP2433622A1 Agent for the prophylaxis and treatment of highly pathogenic infectious diseases
03/28/2012EP2433620A1 Zibotentan Composition
03/28/2012EP2433619A1 Novel antitumoral agent and its therapeutic uses
1 ... 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 ... 7860